6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Encephalomyopathies, Mitochondrial

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Encephalomyopathies, Mitochondrial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Beyrath, J; de Vries, BBA; Hoen, PAC'; Hogeweg, M; Klein Gunnewiek, TM; Kozicz, T; Nadif Kasri, N; Pelgrim, I; Renkema, H; Schoenmaker, C; Smeitink, J; Verboven, AHA	1

Other Studies

1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Encephalomyopathies, Mitochondrial

Article	Year
Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons. Stem cell reports, 2021, 09-14, Volume: 16, Issue:9 Topics: Animals; Astrocytes; Cell Culture Techniques; Cell Differentiation; Cells, Cultured; Chromans; Disease Models, Animal; DNA, Mitochondrial; Gene Expression Profiling; Gene Expression Regulation; Genetic Predisposition to Disease; Heteroplasmy; Humans; Induced Pluripotent Stem Cells; Mitochondrial Encephalomyopathies; Neurons; Phenotype; Rats; RNA, Transfer, Leu; Transcriptome	2021

Article

Year

Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons.

Stem cell reports, 2021, 09-14, Volume: 16, Issue:9

Topics: Animals; Astrocytes; Cell Culture Techniques; Cell Differentiation; Cells, Cultured; Chromans; Disease Models, Animal; DNA, Mitochondrial; Gene Expression Profiling; Gene Expression Regulation; Genetic Predisposition to Disease; Heteroplasmy; Humans; Induced Pluripotent Stem Cells; Mitochondrial Encephalomyopathies; Neurons; Phenotype; Rats; RNA, Transfer, Leu; Transcriptome

2021